South Plainfield, NJ and Boston – September 27, 2016 - GENEWIZ, a leading global genomics services provider, opened a new flagship laboratory in Cambridge, MA on Wednesday September 21st 2016. The addition of Oligo Synthesis and Plasmid Preparation services to the new Cambridge laboratory enhances the local Boston Sanger DNA sequencing services, providing increased speed and convenience to the customer.
The global GENEWIZ network of genomics laboratories¾equipped with the latest technologies and platforms¾offers researchers fast turnaround and unmatched technical support for DNA sequencing, gene synthesis, molecular biology, high-throughput/next-generation sequencing, bioinformatics, and GLP regulatory services.
The GENEWIZ service portfolio is designed with reliability and convenience in mind. “In addition to the expedited local turnaround time for Sanger and Oligo services, the new high-tech laboratory will offer Boston-area customers faster Plasmid Preparation services, from microgram-to-milligram quantities and multiple options for order customization,” said Adrianne Brand, GENEWIZ Cambridge Production Manager.
“GENEWIZ is the only local company offering a combination of on-site Sanger sequencing, plasmid preparation, and oligo synthesis,” according to Dr. Marc Schwartz, Director, Genetic Analysis and Molecular Biology, GENEWIZ. “We are uniquely able to deliver unmet service satisfaction and expedited turnaround to our customers in Boston.”
From left to right: Dr. Marc Schwartz, Director, Genetic Analysis and Molecular Biology, GENEWIZ; Adrianne Brand, GENEWIZ Cambridge Site Manager; Cambridge Vice-Mayor Marc McGovern; Benjamin Bradford of The Life Sciences Center; GENEWIZ CEO and Co-founder Dr. Steve Sun; Herb Hooper, Managing Partner of Ampersand Capital, and Amanda Harrell, Vice President, Global Marketing & Inside Sales at GENEWIZ.
GENEWIZ is a global leader in R&D genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in DNA sequencing, gene synthesis, molecular biology, high throughput sequencing, bioinformatics, and GLP regulatory-compliant services.
Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan. For more information, visitwww.genewiz.com, and connect with us on LinkedIn, Twitter, Facebook, YouTube, and Weibo.